about
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudil...
Read More
1.37
-0.02
(-1.44%)
13,601.3
XNAS Volume
XNAS 13 Jul, 2026 3:44 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Medicinova Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..